Sabbagh, Charles
Mauvais, Francois
Tuech, Jean-Jacques
Tresallet, Christophe
Ortega-Debalon, Pablo
Mathonnet, Muriel
Lefevre, Jeremie H.
Lakkis, Zaher
Fuks, David
Muscari, Fabrice
Dron, Bernard
Couderc, Philippe
Alves, Arnaud
Regimbeau, Jean-Marc
Article History
Received: 6 December 2021
Accepted: 6 February 2022
First Online: 2 March 2022
Declarations
:
: The present study has received ethical approval by the Comité de Protection des personnes on the 29th of novembre 2018 under the number 2017-A00613-50/SI: 18.09.12.65718. All patients have to give a written consent. All patients already included in the study have given a written consent.
: Not applicable.
: Prof. JM Regimbeau has financial interest with thermofisher.